Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maternal Toxicity With Continuous Nevirapine in Pregnancy

10 Jun 2004

Abstract excerpt

OBJECTIVE: To compare the safety of nelfinavir and nevirapine-based antiretroviral treatment in HIV-1-infected pregnant women. METHODS: In Pediatric AIDS Clinical Trials Group Protocol 1022, 38 antiretroviral-naive pregnant women at 10-30 weeks' gestation were randomized to nelfinavir or nevirapine with zidovudine plus lamivudine. The study was suspended because of greater than expected toxicity and changes in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to Pregnancy and Medication Impact

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15213559
DOI: 10.1097/00126334-200407010-00002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Maternal Toxicity With Continuous Nevirapine in PregnancyPMID 15213559Read ↗

Adverse events associated with nevirapine use in pregnancySemantic proximity Read ↗

Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational study.Semantic proximity Read ↗

Pregnancy-Related Effects on Nelfinavir-M8 Pharmacokinetics: a Population Study with 133 WomenSemantic proximity Read ↗

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.Semantic proximity Read ↗

Placenta and Cord Blood Mitochondrial DNA Toxicity in HIV-Infected Women Receiving Nucleoside Reverse Transcriptase Inhibitors During PregnancySemantic proximity Read ↗

African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine.Semantic proximity Read ↗

Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.Semantic proximity Read ↗

Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.Semantic proximity Read ↗

Pregnancy-Related Effects on Tenofovir Pharmacokinetics: a Population Study with 186 WomenSemantic proximity Read ↗

CYP3A4 polymorphism and lopinavir toxicity in an HIV-infected pregnant woman.Semantic proximity Read ↗

Response to antiretroviral therapy after a single, peripartum dose of nevirapine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.